Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks!Unlock list

Skylight Health Group Inc (SLHGF)

OTC Markets
Symbol
Exchange
Currency
SLHGhTSXVCAD
SLHGFOTC MarketsUSD
Currency in USD
Disclaimer
0.003
0.000(0.00%)
Closed

SLHGF Comments

I’m impressed with Skylight Health Group’s recent Q3 ‘22 results - particularly the fact that this tiny $25.4M market cap company has generated $20.8M revenues by Q3. Their future outlook is equally positive now that they’ve reached sufficient scale to organically grow their lines of businesses including Medicare and Medicare Advantage.
Skylight Health Group recently reported positive results from their Q3 ‘22 results including revenue growth of +152% YoY reaching $20.8M. Even stronger results from their cost-saving initiatives reducing annual cost base by $10M+. Their forthcoming strategy is to develop growth organically now they’ve reached sufficient scale and this is through growth in their business lines including Medicare and Medicare Advantage.
Healthcare in the US has always been an important market highly resistant to fluctuations in the economy. $5M isn't a small amount of money, so with a multi-billion dollar company backing them, Skylight has significant potential to scale the business as they continue to develop their clinical network.
The recent capital raise's benefits greatly outweigh the dilution that it'll create. In a market like this, the companies that are improving their margins and have significant backing will be the ones that'll benefit. Echelon Capital even stated that the company could more than triple from here due to growth potential and the current undervalued status against industry peers: https://www.cantechletter.com/2022/10/skylight-health-is-more-than-a-triple-from-here-says-echelon/
The $5M will go a long way for company development. The institutional backing only shows that there's potential for significant growth here as Skylight continues to aggressively expand operations across the US and improve EBIDTA margins each quarter.
One of the main problems with medical clinics today is a lack of optimization both for costs and administration. Skylight's network is creating a more effective environment where patients can get the treatment they need, and the clinic can maximize profitability. Considering the growth projections and current valuation, there's a lot of untapped potential.
Now trading on the OTCQX and have received DTC Eligibility under SLHGF. This means that the company will now have more transparency and will be more visible to US investors who are interested in the company and its rapidly expanding footprint across the US.
Very impressed with the financial results for Q2! Rev increased 184%, 13% organic growth from existing primary care clinics, and $11.8M cash balance. Love to see them achieve their largest rev quarter and ending it with the addition of new clinics, providers and patient panels.
Lake Street recently initiated coverage for $SLHG with a buy rating and a pt of $8. As they continue to acquire clinics and focus on their value-based care model resulting in improved patient care, this one has lots of potential imo.
Skylight Health Group is an extremely unique Healthcare service tech provider operating 30 clinics, across 14 states, and serving over 120,000 patients - and one of the fastest growing multi-disciplinary health systems in the US. With their VBC model for payment disrupting the industry FFS standard, they are market leaders that emphasize quality over volume leading to better patient outcomes, reduced cost for delivery, and driving better financial performance. Their recent ACO partnership acquisitions provide clear and significant strides toward this foundational goal as they will not be participating in the Medicare Shared Savings programs effective Jan 1, 2022. $SLHG is definitely one to watch!
They recently announced the acquisition of Doctors Center Inc., a primary care group with 4 locations in Florida. This addition brings their clinic operations to over 23 locations in 5 states, increases patient count by 6k, with 2020 unaudited revenues of about CAD $3.2M and expected EBITDA margin of 10%. Focused on the highly fragmented US healthcare market, Skylight is expanding rapidly and I'll be buying the dips.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.